Form 4 Tracker
IONIS PHARMACEUTICALS INC
IONS

78 insider filings · Latest: Jul 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 16, 2026Apr 16 10:47 PMBirchler Brian
Proposed Sale
973$75.40$73.4K

View →

Apr 16, 2026Apr 16 10:45 PMBaroldi Joseph
Proposed Sale
5,619$75.40$423.7K

View →

Apr 1, 2026Apr 2 11:43 PMJoseph Klein IIIDirector
Sale
22,321$75.55$1.7M11,014(D)

View →

Apr 2, 2026Apr 2 11:43 PMShannon L. DeversEVP, Chief Human Resources Ofc
Sale
6,193$74.05$458.6K16,348(D)

View →

Mar 3, 2026Mar 31 9:28 PMDiaz Allene M.
Proposed Sale
68,800$79.50$5.5M

View →

Mar 19, 2026Mar 24 8:43 PMSchneider Eugene
Proposed Sale
5,812$70.97$412.5K

View →

Mar 19, 2026Mar 23 11:36 PMEugene SchneiderEVP, Chf Clinical Develop Ofcr
Sale
5,812$70.97$412.5K63,890(D)

View →

Mar 19, 2026Mar 19 8:01 PMSchneider Eugene
Proposed Sale
5,812$70.97$412.5K

View →

Mar 17, 2026Mar 18 9:19 PMHOUGEN ELIZABETH LEVP, Finance & CFO
Sale
10,172$73.21$744.7K82,660(D)

View →

Mar 16, 2026Mar 18 9:19 PMHOUGEN ELIZABETH LEVP, Finance & CFO
Sale
215,048$72.40$15.6M92,832(D)

View →

Mar 16, 2026Mar 16 8:32 PMHOUGEN ELIZABETH L
Proposed Sale
225,200$72.31$16.3M

View →

Mar 9, 2026Mar 11 8:19 PMPatrick R. O'NeilEVP CLO & General Counsel
Sale
10,148$75.25$763.7K62,211(D)

View →

Mar 10, 2026Mar 11 8:19 PMBrett P MoniaDirector, Chief Executive Officer
Sale
34,103$75.92$2.6M242,662(D)

View →

Mar 9, 2026Mar 11 8:19 PMBrett P MoniaDirector, Chief Executive Officer
Sale
126,670$75.20$9.5M242,662(D)

View →

Mar 10, 2026Mar 11 8:18 PMKyle JenneEVP, Chf GL Pdt Str Ofcr
Sale
37,277$75.85$2.8M11,714(D)

View →

Mar 10, 2026Mar 10 8:00 PMJenne Kyle
Proposed Sale
58,253$75.57$4.4M

View →

Mar 9, 2026Mar 9 8:16 PMO'NEIL PATRICK R.
Proposed Sale
13,217$75.25$994.6K

View →

Mar 4, 2026Mar 5 11:14 PMJoseph LoscalzoDirector
Sale
200$80.00$16.0K36,330(D)

View →

Mar 3, 2026Mar 5 11:14 PMJoseph LoscalzoDirector
Sale
832$80.33$66.8K36,330(D)

View →

Mar 3, 2026Mar 5 11:14 PMJoseph Klein IIIDirector
Sale
21,332$79.51$1.7M11,014(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 15, 2026Jul 17 9:13 PMPeter N ReikesDirector
Grant/Award
3,3993,399(D)

View →

Jul 15, 2026Jul 17 9:13 PMLudwig HantsonDirector
Grant/Award
3,3993,399(D)

View →

Jul 15, 2026Jul 17 9:12 PMJoan E HermanDirector
Option Exercise
5,2202,301(D)

View →

Jul 15, 2026Jul 17 9:12 PMBERTHELSEN SPENCER RDirector
Option Exercise
5,2202,301(D)

View →

Jul 7, 2026Jul 9 11:26 PMBENNETT C FRANKEVP, Chief Scientific Officer
Other (J)
15,000$0.0012,109(D)

View →

Jul 7, 2026Jul 9 10:07 PMAllene M. DiazDirector
Option Exercise
10,111$47.110(D)

View →

Jul 1, 2026Jul 6 10:50 PMMichael J. YangDirector
Grant/Award
7,670$79.199,451(D)

View →

Jul 1, 2026Jul 6 10:50 PMJoseph LoscalzoDirector
Grant/Award
7,670$79.197,521(D)

View →

Jul 1, 2026Jul 6 10:49 PMJoan E HermanDirector
Grant/Award
7,670$79.197,521(D)

View →

Jul 1, 2026Jul 6 10:49 PMJoseph Klein IIIDirector
Option Exercise
11,518$39.940(D)

View →

Jul 1, 2026Jul 6 10:49 PMJoseph Klein IIIDirector
Grant/Award
7,670$79.1916,277(D)

View →

Jul 1, 2026Jul 6 10:45 PMMichael R HaydenDirector
Grant/Award
7,670$79.1912,198(D)

View →

Jul 1, 2026Jul 6 10:44 PMAllene M. DiazDirector
Grant/Award
7,670$79.197,521(D)

View →

Jul 1, 2026Jul 6 10:44 PMBERTHELSEN SPENCER RDirector
Grant/Award
7,670$79.197,521(D)

View →

Jun 26, 2026Jun 30 9:48 PMJoseph BaroldiEVP, Chief Business Officer
Option Exercise
5,635$56.780(I)

View →

Jun 26, 2026Jun 30 9:48 PMEugene SchneiderEVP, Chf Clinical Develop Ofcr
Option Exercise
26,000$60.8926,000(D)

View →

Jun 26, 2026Jun 26 11:09 PMBrett P MoniaDirector, Chief Executive Officer
Option Exercise
50,000$56.7899,872(D)

View →

Jun 25, 2026Jun 26 11:09 PMBrett P MoniaDirector, Chief Executive Officer
Option Exercise
21,072$32.600(D)

View →

Jun 24, 2026Jun 26 11:09 PMBrett P MoniaDirector, Chief Executive Officer
Option Exercise
14,565$32.6021,072(D)

View →

Jun 12, 2026Jun 16 9:26 PMHolly B. KordasiewiczEVP, Chief Development Officer
Option Exercise
60,846$60.890(D)

View →

Page 1 of 4

Next →